These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

316 related items for PubMed ID: 33396288

  • 1. A Novel Ebola Virus VP40 Matrix Protein-Based Screening for Identification of Novel Candidate Medical Countermeasures.
    Bennett RP, Finch CL, Postnikova EN, Stewart RA, Cai Y, Yu S, Liang J, Dyall J, Salter JD, Smith HC, Kuhn JH.
    Viruses; 2020 Dec 31; 13(1):. PubMed ID: 33396288
    [Abstract] [Full Text] [Related]

  • 2. Could the Ebola virus matrix protein VP40 be a drug target?
    Stahelin RV.
    Expert Opin Ther Targets; 2014 Feb 31; 18(2):115-20. PubMed ID: 24283270
    [Abstract] [Full Text] [Related]

  • 3. Current status of small molecule drug development for Ebola virus and other filoviruses.
    Edwards MR, Basler CF.
    Curr Opin Virol; 2019 Apr 31; 35():42-56. PubMed ID: 31003196
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Ubiquitin Ligase WWP1 Interacts with Ebola Virus VP40 To Regulate Egress.
    Han Z, Sagum CA, Takizawa F, Ruthel G, Berry CT, Kong J, Sunyer JO, Freedman BD, Bedford MT, Sidhu SS, Sudol M, Harty RN.
    J Virol; 2017 Oct 15; 91(20):. PubMed ID: 28768865
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The Ebola virus matrix protein penetrates into the plasma membrane: a key step in viral protein 40 (VP40) oligomerization and viral egress.
    Adu-Gyamfi E, Soni SP, Xue Y, Digman MA, Gratton E, Stahelin RV.
    J Biol Chem; 2013 Feb 22; 288(8):5779-89. PubMed ID: 23297401
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Targeting ebola virus VP40 protein through novel inhibitors: exploring the structural and dynamic perspectives on molecular landscapes.
    Khan S, Fakhar Z, Ahmad A.
    J Mol Model; 2021 Jan 25; 27(2):49. PubMed ID: 33495861
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. In silico exploration of deep-sea fungal metabolites as inhibitor of Ebola and Marburg VP35 and VP40.
    Alanzi AR, Alajmi MF, Al-Dosari MS, Parvez MK, Alqahtani MJ.
    PLoS One; 2024 Jan 25; 19(7):e0307579. PubMed ID: 39052567
    [Abstract] [Full Text] [Related]

  • 15. Chaperone-Mediated Autophagy Protein BAG3 Negatively Regulates Ebola and Marburg VP40-Mediated Egress.
    Liang J, Sagum CA, Bedford MT, Sidhu SS, Sudol M, Han Z, Harty RN.
    PLoS Pathog; 2017 Jan 25; 13(1):e1006132. PubMed ID: 28076420
    [Abstract] [Full Text] [Related]

  • 16. A biaryl sulfonamide derivative as a novel inhibitor of filovirus infection.
    Isono M, Furuyama W, Kuroda M, Kondoh T, Igarashi M, Kajihara M, Yoshida R, Manzoor R, Okuya K, Miyamoto H, Feldmann H, Marzi A, Sakaitani M, Nanbo A, Takada A.
    Antiviral Res; 2020 Nov 25; 183():104932. PubMed ID: 32946918
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Development of Potential Small Molecule Therapeutics for Treatment of Ebola Virus Disease.
    Schafer A, Cheng H, Lee C, Du R, Han J, Perez J, Peet N, Manicassamy B, Rong L.
    Curr Med Chem; 2018 Nov 25; 25(38):5177-5190. PubMed ID: 29032747
    [Abstract] [Full Text] [Related]

  • 19. Budding of Ebola Virus Particles Requires the Rab11-Dependent Endocytic Recycling Pathway.
    Nanbo A, Ohba Y.
    J Infect Dis; 2018 Nov 22; 218(suppl_5):S388-S396. PubMed ID: 30476249
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.